MENU

Eureka projects

The pregnenolone-derivative MAP4343 as a new therapy for the treatment of depressive disorders: a preclinical project
Cut-off: 
3
Ranking: 
6
Project ID: 
5291

Generation & optimization of anti-FCGR2B antibodies to create tolerizing vaccines for autoimmune diseases and severe allergy
Cut-off: 
3
Ranking: 
16
Project ID: 
5307

Psoriasis Anti-inflammatory Treatment
Cut-off: 
9
Ranking: 
93
Project ID: 
7783

Bicyclic Anti-Inflammatory Therapeutics
Cut-off: 
1
Ranking: 
53
Project ID: 
9073

A low-cost intranasal vaccine that offers universal protection against pneumococcal infections.
Cut-off: 
2
Ranking: 
30
Project ID: 
9285

Combination of a hybrid scaffold material with cold adapted marine enzymes for wound healing
Cut-off: 
3
Ranking: 
87
Project ID: 
9695

Development of a novel anti-invasive drug candidate with improved efficacy for liver cancer therapy
Cut-off: 
4
Ranking: 
105
Project ID: 
10121

A novel topical therapy for Atopic Dermatitis through development of LXR agonists
Cut-off: 
5
Ranking: 
8
Project ID: 
10449

Anti B-Cell 2-specific Antibody for the treatment of chronic Lymphocytic Leukaemia
Cut-off: 
5
Ranking: 
23
Project ID: 
10506

Development of next-generation treatment for allergies: targeted glycan-allergen immunotherapy
Cut-off: 
5
Ranking: 
74
Project ID: 
10545

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.